Israeli medical device company Cheetah Medical has raised $14.5 million in its quest to raise $24.1 million. 

The company makes the NICOM cardiac output monitor, what its website describes as the only non invasive cardiacand hemodynamic monitoring system that helps physicians manage fluids in critically ill patients.

The system bears the CE Mark and is also cleared by the FDA. The company has conducted several studies to prove the efficacy of the device.  

A news release published in September shows that the latest study proved that the NICOM product has a high level of accuracy. Specifically it measured the stroke volume index and a change of more than 10 percent in that index showed that the patient had good fluid response.  

"As critical care physicians we understand that determining a patient's fluid status is essential to our ability to provide safe and effective treatments to our patients. Fluid optimization is the cornerstone of medical management in many of our patients, most notably those suffering from sepsis, trauma, acute kidney injury and those recovering from major surgical interventions," said Dr. Jordan Bonomo, Director, Division of Critical Care, Department of Emergency Medicine, University of Cincinnati College of Medicine, in the news release. "This research further validates my experience in using NICOM monitoring, along with the PLR maneuver, in the management of critically ill patients."

[PLR is passive leg raise where the leg is raised to bring blood from the lower extremities toward the heart.]

Cheetah Medical's U.S. headquarters is in Vancouver, Washington and the company is led by Chris Hutchinson. Hutchinson, who is based in Boston according to his LinkedIn profile, appears to have recently replaced Yoav Avidor, the previous CEO. Avidor is now running Drink Sciences, a company he founded in March. 

-- By Arundhati Parmar, Senior Editor, MD+DI

Related Content

Startup that Makes Sensor to Track Use of Asthma Inhaler Raises Nearly $7 million

Company developing minimally invasive procedure for GERD and obesity raises $3 million